Announcements Trials
Browse Landscape

Phase

Phase 2 56Phase 1 11Phase 1/2 10Phase NA 6Phase 3 2

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia, Myeloid, Acute 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Myeloproliferative Disorders 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Leukemia, Lymphocytic, Chronic, B-Cell 5Myelodysplastic Syndromes 4Multiple Myeloma 4Lymphoma, Non-Hodgkin 4Hodgkin Disease 4Graft vs Host Disease 4Lymphoma, Mantle-Cell 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Waldenstrom Macroglobulinemia 2Primary Myelofibrosis 2Myasthenia Gravis 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Biphenotypic, Acute 2Leukemia 2Hematologic Neoplasms 2Anemia, Refractory, with Excess of Blasts 2Testicular Neoplasms 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Neoplasms, Plasma Cell 1Neoplasms 1Myeloproliferative Syndrome, Transient 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

Cytarabine 68Cyclophosphamide 44Methotrexate 41Daunorubicin 38Etoposide 34Vincristine 30Mercaptopurine 28Dexamethasone 24Radiotherapy 22Idarubicin 22Asparaginase 21Thioguanine 20Doxorubicin 19Prednisone 17Peripheral Blood Stem Cell Transplantation 17Imatinib Mesylate 16Busulfan 16pegaspargase 15Mitoxantrone 15Filgrastim 13Leucovorin 11fludarabine phosphate 10Hydrocortisone 10nilotinib 9Tretinoin 8Prednisolone 8Cyclosporine 8Hydroxyurea 7Epoetin Alfa 7Azacitidine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Leukemia × Mycophenolic Acid × Clear all
NCT04547049 2026-04-09

A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies

First Affiliated Hospital of Zhejiang University

Phase 3 Active not recruiting
232 enrolled
Other hematologic neoplasm

Leukemia

NCT00568633 2019-09-24

Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML

Stanford University

Phase 3 Terminated
58 enrolled 18 charts
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡